Rezolute, Inc. — Director's Dealing 2015

Dec 21, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AntriaBio, Inc. (ANTB)
CIK: 0001509261
Period of Report: 2015-12-10

Reporting Person: Welch David F (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-12-10	Series A Convertible Preferred Stock	$1.95	P	256410	Acquired		Common Shares (256410)	Indirect

Footnotes

F1: The Series A Preferred Stock is convertible into common stock of Issuer at a price per share of $1.95, subject to the terms and conditions of the Private Placement Memorandum dated November 3, 2015.

F2: The Series A Preferred Stock has no expiration date.

F3: LRFA, LLC owns shares of common stock, warrants to purchase common stock and Series A Preferred Stock convertible into common stock of Issuer. Dr. Welch is President of LRFA, LLC and has voting and dispositive power of the shares of the Issuer's common stock held by LRFA, LLC.